Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review. [PDF]
García-Díaz M +3 more
europepmc +1 more source
THE ARGUMENTS IN TAX DISPUTES ON VAT
openaire +1 more source
ESG Controversies in Global Firms: A Black Mark?
ABSTRACT Despite increasing attention paid by companies to sustainability, there is still evidence of environmental, social and governance (commonly referred to as ESG) scandals. As research on this topic is scant, this paper aims to analyse the impact of ESG controversies on firms' sustainability practices, that is, ESG policies, as well as ...
Beatrice Bais, Guido Orzes, Marco Sartor
wiley +1 more source
Debates over orphan drug pricing: a meta-narrative literature review. [PDF]
Hanchard MS.
europepmc +1 more source
Fueling Tomorrow: Scenario Planning for the Future of Gas Stations
ABSTRACT Transport electrification is reshaping the service infrastructures that mediate everyday mobility, yet most electrification scenario studies remain macrolevel and offer limited insight into how incumbent forecourt (gas‐station) networks can adapt under deep uncertainty.
Joao Gabriel Rosa +2 more
wiley +1 more source
Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy. [PDF]
Bertscher A +8 more
europepmc +1 more source
ABSTRACT Reaching global net‐zero targets has become an urgent priority as businesses and nations face increasing pressure to reduce greenhouse gas emissions. Achieving carbon neutrality in manufacturing supply chains requires comprehensive systemic changes across business processes.
Vimal K. E. K. +5 more
wiley +1 more source
Fanning the flame: analysing the emergence, implications, and challenges of Australia's de facto war on Nicotine. [PDF]
Martin J, Jegasothy E.
europepmc +1 more source
ABSTRACT This study investigates companies' responses to energy efficiency policies, focusing on mandatory and voluntary regulations that create a complex landscape for businesses to navigate. Using a sample of 1473 firms across 29 European countries (2002–2018), we explore the impact of legislation on green redesign—operationalized through ...
Thomas Alexopoulos +3 more
wiley +1 more source
Stretching Scarce Authorizing Legislation as Far as Possible: A Legislative History of the 340B Drug Pricing Program. [PDF]
Nikpay S, Reinke M, Quinones N.
europepmc +1 more source

